Ann Arbor, MI, United States of America

Ibrahim Oraiqat

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Radiotherapy: The Contributions of Ibrahim Oraiqat

Introduction

Ibrahim Oraiqat is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of radiotherapy, particularly in the development of advanced imaging techniques that enhance cancer treatment. With a total of 2 patents, Oraiqat's work focuses on improving the accuracy and effectiveness of radiation therapy.

Latest Patents

Oraiqat's latest patents include groundbreaking technologies that combine radiation acoustics and ultrasound for radiotherapy guidance and cancer targeting. This method utilizes combined ultrasound and ionizing radiation induced acoustic imaging (iRAI) computed tomography imaging techniques. It allows for the measurement of low to ultrahigh dose deliveries exceeding 40 Gy/s. The system employs multiplexed transducers to detect ultrasound and iRAI signals, facilitating anatomical and functional imaging along with radiation mapping. This innovation provides absolute dosimetry measurements during radiotherapy sessions, ensuring precise radiation delivery to tumors while protecting healthy tissues.

Another notable patent involves silicon photomultiplier array-based multispectral optical probes for image-guided radiotherapy. This technology leverages Cerenkov Emission (CE) during external beam radiation therapy (EBRT) from a linear accelerator (Linac). It addresses the challenge of molecular probing of cancer status during treatment, which has been limited by detection sensitivity. Oraiqat's work assesses the feasibility of using silicon photomultipliers (SiPMs) for low light detection, offering improved flexibility in device design and enhancing the tracking of tumors during treatment.

Career Highlights

Oraiqat is affiliated with the University of Michigan, where he continues to advance research in radiotherapy. His innovative approaches have garnered attention in the medical community, contributing to the ongoing evolution of cancer treatment methodologies.

Collaborations

Oraiqat collaborates with esteemed colleagues, including Issam El Naqa and Xueding Wang, to further enhance the impact of his research and innovations in the field of radiotherapy.

Conclusion

Ibrahim Oraiqat's contributions to radiotherapy through his innovative patents demonstrate his commitment to improving cancer treatment. His work not only enhances the precision of radiation delivery but also aims to minimize harm to healthy tissues, marking significant advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…